It's better than a poke in the eye with a burnt stick, but..
They have the time to make announcements about this non-price sensitive fluff, just highlights how easy it would be for them to keep the market updated about the much more interesting matters like number of patients treated, requests for treatment/product, medium term forecasts, partnerships etc.
Ann: Meeting Requested with FDA on Revascor Accelerated Approval, page-10
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.38 |
Change
-0.070(2.86%) |
Mkt cap ! $3.046B | |||
| Open | High | Low | Value | Volume |
| $2.45 | $2.48 | $2.35 | $8.936M | 3.711M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 34219 | $2.37 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.39 | 25304 | 4 |
View Market Depth
| Last trade - 16.15pm 31/07/2025 (20 minute delay) ? |
| MSB (ASX) Chart |